Research Article

Patient Characteristics and Outcomes of Outpatient Parenteral Antimicrobial Therapy: A Retrospective Study

Table 1

OPAT patient characteristics and outcomes.

VariablesTotal
()
Return to ED or readmission
()
No return to ED or readmission
()
value

Age, years [median (IQR)]63 (43–74)64 (43–74)61 (45–75)0.95
Male65 (63%)28 (58%)37 (66%)0.42
Length of stay, days [median (IQR)]7 (6–10)7 (6–10)7 (6–10)0.28
Admitting service
 Medical47 (45%)23 (48%)24 (43%)0.61
 Surgical57 (55%)25 (52%)32 (57%)0.61
Prior admission within past 12 months59 (57%)31 (65%)28 (50%)0.13
History of antibiotic-resistant organisms24 (23%)13 (27%)11 (20%)0.37
Comorbidities
 Hypertension46 (44%)24 (50%)22 (39%)0.27
 Diabetes29 (28%)18 (38%)11 (20%)0.04
 Gastrointestinal disease29 (28%)16 (33%)13 (23%)0.25
 Cancer27 (26%) 17 (35%)10 (18%)0.04
 Coronary artery disease23 (22%)7 (15%)16 (29%)0.09
 Peripheral vascular disease13 (13%)6 (13%)7 (13%)1.00
 Arrhythmia12 (12%)5 (10%)7 (13%)0.74
Documented follow-up plan at discharge
 Admitting service71 (68%)32 (67%)39 (70%)0.75
 Infectious diseases58 (56%)27 (56%)31 (55%)0.93
 Family physician35 (34%)13 (27%)22 (39%)0.19
Most common antimicrobials
 Ceftriaxone22 (21%)10 (21%)12 (21%)0.94
 Cefazolin21 (20%)8 (17%)13 (23%)0.41
 Piperacillin-tazobactam15 (14%)4 (8%)11 (20%)0.10
 Cloxacillin15 (14%)10 (21%)5 (9%)0.08
 Vancomycin14 (13%)6 (13%)8 (14%)0.79
 Ertapenem13 (13%)8 (17%)5 (9%)0.23
Syndrome
 Surgical site infection34 (33%)14 (29%)20 (36%)0.48
 Osteoarticular infection229 (28%)13 (27%)16 (29%)0.87
 Bacteremia22 (21%)14 (29%)8 (11%)0.06
 Cellulitis18 (17%)9 (19%)9 (16%)0.72
 Urinary tract infection16 (15%)12 (25%)4 (7%)0.01
 Endocarditis7 (7%)4 (8%)3 (5%)0.70
Patient outcomes3
 No events56 (54%)56 (100%)
 Events due to infection relapse17 (16%)17 (35%)
 Events due to treatment failure6 (6%)6 (13%)
 Events due to OPAT-related complications11 (11%)11 (23%)
 Events due to unrelated causes14 (13%)14 (29%)

Values are expressed as number (%) unless otherwise stated.
Less commonly used antimicrobials included ciprofloxacin, metronidazole, meropenem, clindamycin, fluconazole, cephalexin, rifampin, ceftazidime, ampicillin, penicillin G, nitrofurantoin, doxycycline, and voriconazole.
Including 4 cases of diabetic foot infections and 1 case of prosthetic joint infection.
Event defined as readmission or emergency department (ED) visit within 60 days of discharge.
IQR: interquartile range.